0NHS.L0NHS.LLSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank43
3Y CAGR-12.3%
5Y CAGR+10.4%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-12.3%/yr
vs +34.5%/yr prior
5Y CAGR
+10.4%/yr
Recent deceleration
Acceleration
-46.9pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM22.72%+40.1%
202416.22%-3.5%
202316.81%-50.2%
202233.73%+42.0%
202123.75%+71.7%
202013.83%-24.2%
201918.25%+77.2%
201810.30%-48.1%
201719.86%-23.5%
201625.96%-